natgillin/translations-raw huggingface dataset:
The recommended dose is 20 micrograms of Forsteo given once a day as an injection under the skin of the thigh or abdomen (tummy). 
Priporočeni odmerek je 20 mikrogramov zdravila Forsteo, ki se daje enkrat dnevno v obliki injekcije pod kožo stegna ali predela trebuha.
Forsteo is used for the treatment of osteoporosis (a disease that makes bones fragile) in the following groups: 
Zdravilo Forsteo se uporablja za zdravljenje osteoporoze (bolezni, ki povzroča krhkost kosti) pri naslednjih skupinah:
What is the risk associated with Forsteo? 
Kakšna tveganja so povezana z zdravilom Forsteo?
It acts like the hormone to stimulate bone formation by acting on osteoblasts (bone-forming cells). 
Deluje enako kot hormon in vzpodbuja tvorbo kosti tako, da deluje na osteoblaste (celice, ki tvorijo kostnino).
The CHMP concluded that Forsteo's benefits are greater than its risks and recommended that it be given marketing authorisation. 
Odbor za zdravila za uporabo v humani medicini (CHMP) je zaključil, da so koristi zdravila Forsteo večje od z njim povezanih tveganj, in priporočil, da se zanj izda dovoljenje za promet.
The studies also showed that the benefits of Forsteo treatment continued to increase for up to two years, with further increases in bone density. 
Študije so tudi pokazale, da so bile koristi zdravljenja z zdravilom Forsteo vedno večje v obdobju do največ dveh let, saj se je gostota kosti nadalje povečevala.
Patients should receive calcium and vitamin D supplements if they do not get enough from their diet. Forsteo can be used for up to two years. 
Bolniki morajo jemati tudi dodatek kalcija in vitamina D, če ju ne dobivajo dovolj s prehrano.
In these patients, Forsteo has been shown to significantly reduce vertebral (spine) and non-vertebral fractures (broken bones), but not those of the hip; 
Pri teh bolnicah je bilo dokazano, da zdravilo Forsteo znatno zmanjšuje pojavnost zlomov vretenc (hrbtenice) in nevretenčnih zlomov, ne pa tudi zlomov kolka;
The active substance in Forsteo, teriparatide, is identical to part of the human parathyroid hormone. 
Zdravilna učinkovina v zdravilu Forsteo, teriparatid, je enaka delu človeškega paratiroidnega hormona.
In the study of patients taking glucocorticoids, Forsteo was more effective than alendronate: after 18 months, patients receiving Forsteo had a 7% increase in bone density in the spine, compared with 3% in those receiving alendronate. 
V študiji bolnikov, ki so jemali glukokortikoide, je bilo zdravilo Forsteo učinkovitejše od alendronata: po 18 mesecih se je pri bolnikih, ki so prejemali zdravilo Forsteo, gostota kosti v hrbtenici povečala za 7 % v primerjavi s 3 % pri bolnikih, ki so prejemali alendronat.
The first study involved 1,637 women with osteoporosis who had been through the menopause (average age: 69.5 years), in which Forsteo was compared with placebo (a dummy treatment) for an average of 19 months. 
V prvo študijo je bilo vključenih 1 637 žensk (povprečna starost: 69,5 leta) s pomenopavzalno osteoporozo, v kateri so zdravilo Forsteo v obdobju povprečno 19 mesecev primerjali s placebom (zdravilom brez zdravilne učinkovine).
The second study looked at the use of Forsteo in 437 men with osteoporosis, comparing its effect on the density of bones in the spine with that of placebo. 
V drugi študiji so proučevali uporabo zdravila Forsteo pri 437 moških z osteoporozo in primerjali njegov učinek na gostoto kosti v hrbtenici z učinkom placeba.
Forsteo is a medicine that contains the active substance teriparatide. 
Forsteo je zdravilo, ki vsebuje zdravilno učinkovino teriparatid.
An additional study looked at the effects of Forsteo on bone density over two years in 234 women who had been through the menopause. 
V dodatni študiji so dve leti proučevali učinke zdravila Forsteo na gostoto kosti pri 234 ženskah po menopavzi.
The third study compared the effects of Forsteo and alendronate (another medicine used to treat osteoporosis) on spine bone density over three years. 
V tretji študiji so tri leta primerjali učinke zdravila Forsteo in alendronata (drugega zdravila za zdravljenje osteoporoze) na gostoto kosti v hrbtenici.
Forsteo was more effective than placebo in reducing vertebral fractures: 5% of the women who received Forsteo had a new fracture during the study, compared with 14% in the group who received placebo. 
Zdravilo Forsteo je bilo pri zmanjševanju pojavnosti zloma vretenc učinkovitejše od placeba: pri 5 % žensk, ki so prejemale zdravilo Forsteo, je med študijo prišlo do novega zloma vretenc v primerjavi s 14 % bolnic v skupini, ki je prejemala placebo.
Only one two-year course of Forsteo should be given to a patient in their lifetime. 
Bolniki lahko v času življenja prejmejo samo en dvoletni cikel zdravljenja z zdravilom Forsteo.
In the study in men, Forsteo increased bone density in the spine by about 6% after an average of almost 12 months. 
V študiji, v katero so bili vključeni moški, je zdravilo Forsteo v povprečnem obdobju skoraj 12 mesecevpovečalo gostoto kosti v hrbtenici za okoli 6 %.
Why has Forsteo been approved? 
Zakaj je bilo zdravilo Forsteo odobreno?
What is Forsteo used for? 
Za kaj se zdravilo Forsteo uporablja?
For the full list of all side effects reported with Forsteo, see the package leaflet. 
Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila Forsteo, glejte navodilo za uporabo.
How has Forsteo been studied? 
Kako je bilo zdravilo Forsteo raziskano?
Forsteo reduced the risk of developing a new vertebral fracture over 19 months by 65% compared with placebo. 
Zdravilo Forsteo je v primerjavi s placebom za 65 % zmanjšalo tveganje za pojav novega zloma vretenc v 19-mesečnem obdobju študije.
How is Forsteo used? 
Kako se zdravilo Forsteo uporablja?
Other information about Forsteo 
Druge informacije o zdravilu Forsteo:
You may then hear or feel a click. 
Pri tem lahko slišite ali čutite klik.
This is especially important if you take more than one type of insulin. 
To je zlasti pomembno, če jemljete več kot eno vrsto insulina.
• how much Tresiba you will need each day 
• koliko zdravila Tresiba boste potrebovali vsak dan,
CI: 95% confidence interval. 
IZ: 95 % interval zaupanja.
What others need to do if you pass out 
Kaj morajo narediti drugi, če se onesvestite
4 Episodes from week 16 in each treatment period 
4 Epizode od 16. tedna v vsakem obdobju zdravljenja.
The signs of a serious allergic reaction are: 
Znaki resne alergijske reakcije so:
ATC code: A10AE06. 
Oznaka ATC: A10AE06.
These reactions are usually mild and transitory and they normally disappear during continued treatment. 
Te reakcije so ponavadi blage in prehodne in med nadaljevanjem zdravljenja ponavadi izginejo.
This may constitute a risk in situations where these abilities are of special importance (e.g. driving a car or using machines). 
To je lahko nevarno v okoliščinah, v katerih sta ti zmožnosti posebej pomembni (npr. pri vožnji avta ali upravljanju strojev).
Ask your doctor whether you can drive if: 
Vprašajte zdravnika, ali lahko vozite, v primeru da:
This medicinal product must not be mixed with any other medicinal products. 
Tega zdravila se ne sme mešati s katerim koli drugim zdravilom.
• the local reactions spread to other parts of your body 
• razširitev lokalnih reakcij na druge dele telesa,
This is normal, but you must still check the insulin flow. 
To je normalno, vendar morate kljub temu preveriti pretok insulina.
If you have poor eyesight, please see section 3. 
Če slabo vidite, glejte poglavje 3.
• Do not leave the pen in a car or other place where it can get too hot or too cold. 
• Ne puščajte injekcijskega peresnika v avtomobilu ali na drugem mestu, kjer bi lahko postal preveč vroč ali hladen.
For more information, see ‘serious allergic reaction' above. 
Za dodatne informacije glejte odstavek »Resna alergijska reakcija« zgoraj.
Your doctor will decide together with you: 
Skupaj z zdravnikom se bosta odločila:
Do not stop using your insulin without talking to your doctor. 
Ne prenehajte uporabljati vašega insulina, ne da bi se pogovorili z zdravnikom.
6 seconds 
6 sekund
Date of latest renewal: 21 September 2017 
Datum prve odobritve: 21. januar 2013 Datum zadnjega podaljšanja: 21. september 2017
• Always follow your doctor's recommendation for dose. 
• Vedno upoštevajte zdravnikova priporočila glede odmerka.
Before first use 
Pred prvo uporabo
Be especially aware of the following: 
Še posebej morate biti pozorni na:
Tresiba which has been frozen must not be used. 
Zdravila Tresiba, ki je bilo zamrznjeno, se ne sme uporabiti.
Any waste material should be disposed of in accordance with local requirements. 
Odpadni material zavrzite v skladu z lokalnimi predpisi.
All cause death 
Smrt zaradi katerega koli vzroka
Flexibility in dosing time 
Prilagodljivost glede časa odmerjanja
Safety and efficacy have been demonstrated in a long term trial in children aged 1 to less than 18 years. 
Varnost in učinkovitost sta bili dokazani v dolgoročnem preskušanju pri otrocih, starih od 1 leta do 18 let.
<1/1,000); very rare (<1/10,000) and not known (cannot be estimated from the available data). 
< 1/1.000), zelo redki (< 1/10.000) in neznana (pogostnosti ni mogoče oceniti iz razpoložljivih podatkov).
• turn you on your side 
• položiti na bok,
52 weeks of treatment 
52 tednov zdravljenja
This is a build-up of acid in the blood because the body is breaking down fat instead of sugar. 
To je kopičenje kisline v krvi, ker telo presnavlja maščobo namesto sladkorja.
• If you do not respond to a glucagon injection, you will have to be treated in a hospital. 
• Če se ne odzovete na injekcijo z glukagonom, bo potrebno zdravljenje v bolnišnici.
After delivery, insulin requirements usually return rapidly to pre-pregnancy values. 
Po porodu se potreba po insulinu običajno hitro vrne na vrednosti pred nosečnostjo.
26 weeks of treatment 
26 tednov zdravljenja
When using other medicines, ask your doctor if your treatment needs to be adjusted. 
V primeru uporabe drugih zdravil se z zdravnikom posvetujte, ali je treba vaše zdravljenje prilagoditi.
Glucose must be given intravenously if the patient does not respond to glucagon within 10 to 15 minutes. 
Glukozo je treba dati intravensko v primeru, da se bolnik v 10 do 15 minutah ne odzove na glukagon.
• when to check your blood sugar level and if you need a higher or lower dose. 
• kdaj morate preveriti koncentracijo krvnega sladkorja in ali potrebujete višji ali nižji odmerek.
• you have had too low blood sugar a few times recently. 
• ste imeli pred kratkim večkrat prenizek krvni sladkor.
You should therefore monitor your blood sugar level more often than usual. 
Koncentracijo krvnega sladkorja morate torej kontrolirati bolj pogosto kot običajno.
This medicinal product is for use by one person only. 
To zdravilo je namenjeno uporabi ene same osebe.
Do not inject it into a vein or muscle. 
Nikoli ga ne injicirajte v veno ali mišico.
• you suddenly feel unwell with sweating 
• nenadno slabo počutje in znojenje,
This medicinal product can be used in adolescents and children from the age of 1 year (see section 5.1). 
To zdravilo se lahko uporablja pri mladostnikih in otrocih, starejših od 1 leta (glejte poglavje 5.1).
• Get medical help straight away. 
• Nemudoma poiščite zdravniško pomoč.
• Leave the needle under the skin for at least 6 seconds to make sure you get your full dose. 
• Pustite iglo pod kožo vsaj 6 sekund, da zagotovite injiciranje celotnega odmerka.
After first opening: Do not refrigerate. 
Po prvem odprtju: ne shranjujte v hladilniku.
• Please also read the manual that comes with your insulin delivery system. 
• Preberite tudi priročnik, ki ste ga dobili s sistemom za dajanje insulina.
IDeg 0.6 units/kg 
IDeg 0,6 enot/kg
• if you are allergic to insulin degludec or any of the other ingredients of this medicine (listed in section 6). 
• če ste alergični na insulin degludek ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
Insulin requirements usually decrease in the first trimester and increase subsequently during the second and third trimesters. 
Potreba po insulinu se v prvem trimesečju ponavadi zmanjša, potem pa se v drugem in tretjem trimesečju zveča.
This causes swelling around your ankles and other joints. 
To povzroči otekline okrog gležnjev in drugih sklepov.
6 How much insulin is left? 
6 Koliko je preostalega insulina?
Never use a bent or damaged needle. 
Nikoli ne uporabljajte zvite ali poškodovane igle.
Avoiding too low blood sugar (hypoglycaemia) is particularly important for the health of your baby. 
Preprečevanje prenizkega krvnega sladkorja (hipoglikemije) je še posebej pomembno za zdravje vašega otroka.
• If you want to change your usual diet, check with your doctor, pharmacist or nurse first as a change in diet may alter your need for insulin. 
• Če želite spremeniti svojo običajno prehrano, se najprej posvetujte z zdravnikom, farmacevtom ali medicinsko sestro, kajti sprememba prehrane lahko spremeni vaše potrebe po insulinu.
A specific overdose for insulin cannot be defined. 
Specifičnega prevelikega odmerjanja insulina ni mogoče opredeliti.
Avoidance of medication errors 
Preprečevanje napak pri zdravljenju
EXP After first opening: Use within 8 weeks 
EXP Po prvem odprtju: porabite v 8 tednih.
Use in elderly (≥65 years old) 
Uporaba pri starejših (≥ 65 let)
After first opening: Use within 8 weeks 
Po prvem odprtju: porabite v 8 tednih.
*Produced in Saccharomyces cerevisiae by recombinant DNA technology. 
*Pridobljen iz Saccharomyces cerevisiae s tehnologijo rekombinantne DNA.
The half-life of Tresiba is approximately 25 hours independent of dose. 
Razpolovni čas zdravila Tresiba je približno 25 ur, neodvisno od odmerka.
Frequency categories are defined according to the following convention: Very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to 
Skupine pogostnosti so opredeljene po naslednjem dogovoru: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do
If not treated, this could lead to diabetic coma and eventually death. 
Če ga ne zdravite, lahko povzroči diabetično komo in navsezadnje smrt.
Listed below are the most common medicines which may affect your insulin treatment. 
Spodaj so našteta najpogostejša zdravila, ki lahko vplivajo na vaše zdravljenje z insulinom.
This medicinal product has no or negligible influence on the ability to drive and use machines. 
To zdravilo nima ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja strojev.
Antibody development was sparse and had no clinical impact. 
Razvoj protiteles je bil redek in ni imel kliničnega pomena.
The ratio between AUCGIR,0-12h,SS and AUCGIR,τ,SS was 0.5. 
Razmerje med AUCGIR,0-12h,SS in AUCGIR,τ,SS je bilo 0,5.
CV: within-patient coefficient of variation in % 
CV: intraindividualni koeficient spremenljivosti v %
After first opening or if carried as a spare 
Po odprtju ali ko ga imate pri sebi kot rezervo
Nocturnal 
Nočne
Detailed instructions for use are provided on the other side of this leaflet. 
Podrobna navodila najdete na drugi strani tega navodila za uporabo.
If necessary, clean it with mild detergent on a moistened cloth. 
Če je potrebno, ga očistite s krpo, navlaženo z blagim detergentom.
• Always keep your pen and needles out of sight and reach of others, especially children. 
• Injekcijski peresnik in igle vedno hranite zunaj pogleda in dosega drugih, zlasti otrok.
In rats, insulin degludec was secreted in milk; the concentration in milk was lower than in plasma. 
Pri podganah se je insulin degludek izločal v mleko; koncentracija v mleku je bila nižja kot v plazmi.
Hypoglycaemia may occur if the insulin dose is too high in relation to the insulin requirement (see sections 4.5, 4.8 and 4.9). 
Hipoglikemija se lahko pojavi, če je odmerek insulina prevelik glede na potrebo po insulinu (glejte poglavja 4.5, 4.8 in 4.9).
In both treatment arms, children aged 6-11 years had a numerically higher rate of confirmed hypoglycaemia than in the other age groups. 
V obeh skupinah zdravljenja so pri otrocih, starih 6 - 11 let, poročali o številčno večjem deležu potrjene hipoglikemije kot v drugih starostnih skupinah.
Dose counter stopped: 52 units left 
števec odmerka se je ustavil: ostalo je še 52 enot primer
Patients in the Tresiba arm included 43 children aged 1-5 years, 70 children aged 6-11 years and 61 adolescents aged 12-17 years. 
V skupino, ki je prejemala zdravilo Tresiba, je bilo vključenih 43 otrok, starih 1 - 5 let, 70 otrok, starih 6 - 11 let, in 61 mladostnikov, starih 12 - 17 let.
• you experience difficulty in breathing 
• težko dihanje,
• If you are given glucagon, you will need sugar or a sugary snack as soon as you come round. 
• Če dobite injekcijo glukagona, boste potrebovali sladkor ali sladek prigrizek, takoj ko se zaveste.
Paediatric population The European Medicines Agency has waived the obligation to submit the results of trials with Tresiba in: 
Pediatrična populacija Evropska agencija za zdravila je odstopila od obveze za predložitev rezultatov preskušanj z zdravilom
Tresiba helps your body reduce your blood sugar level. 
Zdravilo Tresiba pomaga telesu zniževati količino krvnega sladkorja.
The recommended daily starting dose is 10 units followed by individual dosage adjustments. 
Priporočeni začetni dnevni odmerek je 10 enot, čemur sledi prilagoditev odmerjanja posamezniku.
This should be kept in mind if treatment with the combination of pioglitazone and Tresiba is considered. 
To je treba upoštevati pri načrtovanju zdravljenja s kombinacijo pioglitazona in zdravila Tresiba.
Tresiba is to be dosed in accordance with the individual patient's needs. 
Zdravilo Tresiba je treba odmerjati glede na potrebe posameznega bolnika.
• anabolic steroids, such as testosterone 
• anabolne steroide (na primer testosteron),
This medicinal product must not be administered intramuscularly as it may change the absorption. 
Tega zdravila se ne sme aplicirati intramuskularno, ker lahko povzroči spremembo v absorpciji.
This helps you to ensure that you get your full insulin dose. 
Tako zagotovite, da dobite celoten odmerek insulina.
Time since injection (hours) Treatment 
Čas od injiciranja insulina (v urah) Zdravljenje
If no drop appears, repeat steps 2A to 2C up to 6 times. 
Če se kapljica ne pojavi, ponovite korake od 2A do 2C, vendar ne več kot 6 krat.
The MAH shall agree on the final text of the Direct Healthcare Professional Communication letter and the content of the patient brochure together with a communication plan, with the National Competent Authority in each Member State prior to distribution of the educational pack in the Member State. 
Imetnik dovoljenja za promet bo končno besedilo neposrednega pisma zdravstvenim delavcem, vsebino brošure za bolnike in načrt komuniciranja pred distribucijo izobraževalnega gradiva v državi članici uskladil v dogovoru s pristojnim nacionalnim organom v vsaki državi članici.
Elderly (≥65 years old) 
Starejši (≥ 65 let)
The affinity of insulin degludec to serum albumin corresponds to a plasma protein binding of >99% in human plasma. 
Porazdelitev Afiniteta insulina degludek za serumski albumin ustreza > 99 % vezavi na plazemske beljakovine v človeški plazmi.
It is not known if Tresiba affects the baby in pregnancy or during breast-feeding. 
Ni znano, ali zdravilo Tresiba vpliva na otroka med nosečnostjo ali dojenjem.
Transferring a patient to another type, brand or manufacturer of insulin must be done under medical supervision and may result in the need for a change in dosage. 
Prehod bolnika na drugo vrsto, znamko ali izdelovalca insulina mora potekati pod zdravniškim nadzorom in ima lahko za posledico spremembo odmerka.
• Mild hypoglycaemic episodes can be treated by oral administration of glucose or other products containing sugar. 
• Blage epizode hipoglikemije je mogoče zdraviti z zaužitjem glukoze ali drugih izdelkov, ki vsebujejo sladkor.
Detailed information on this medicinal product is available on the web site of the European Medicines Agency http://www.ema.europa.eu 
Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila http://www.ema.europa.eu
It must not be refilled. 
Ne sme se ga znova polniti.
• Use Tresiba once each day, preferably at the same time every day. 
• Zdravilo Tresiba uporabljajte enkrat na dan, po možnosti vsak dan ob istem času.
This can only be given by someone who knows how to use it. 
Injicira vam ga lahko samo oseba, ki ga zna ustrezno uporabljati.
4 Inject your dose 
4 Injicirajte odmerek
MI: Myocardial infarction. 
MI: Miokardni infarkt.
Tell them what could happen if your blood sugar gets too low, including the risk of passing out. 
Povejte jim, kaj se lahko zgodi v primeru prenizkega krvnega sladkorja, vključno s tveganjem, da se onesvestite.
During a period of 24 hours with once-daily treatment, the exposure of insulin degludec was evenly distributed between the first and second 12 hours. 
V prvih 24 urah zdravljenja enkrat na dan je bila izpostavljenost insulinu degludek enakomerno porazdeljena med prvimi in drugimi 12 urami.
Tresiba can be used in elderly. 
Zdravilo Tresiba se lahko uporablja pri starejših.
6 The ratio is for Tresiba Flex/Tresiba. 
6 To je razmerje med Tresiba Flex/Tresiba.
The 0 must line up with the dose pointer. 
Število 0 mora biti poravnano s kazalnikom odmerka.
No safety issues were identified with Tresiba with respect to adverse events and standard safety parameters. 
Pri uporabi zdravila Tresiba niso ugotovili težav z varnostjo v smislu neželenih učinkov in običajnih parametrov varnosti.
• Neonates and infants from birth to less than 12 months of age with type 1 diabetes mellitus and children from birth to less than 10 years of age with type 2 diabetes mellitus on the grounds that the disease or condition for which the specific medicinal product is intended does not occur in the specified paediatric subset (see section 4.2 for information on paediatric use). 
• novorojenčke in dojenčke, od rojstva do manj kot 12 mesecev starosti, s sladkorno boleznijo tipa 1 ter za otroke, od rojstva do manj kot 10. leta starosti, s sladkorno boleznijo tipa 2 z utemeljitvijo, da se bolezen ali stanje, za katero je namenjeno to zdravilo, v tej podskupini pediatričnih bolnikov ne pojavlja (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2);
Careful control of your diabetes is needed in pregnancy. 
Med nosečnostjo je potreben skrben nadzor vaše sladkorne bolezni.
Steady state will occur after 2-3 days of dose administration. 
Stanje dinamičnega ravnovesja bo doseženo po 2-3 dneh uporabe zdravila.
If you select a wrong dose, you can turn the dose selector forwards or backwards to the correct dose. 
Če izberete napačen odmerek, lahko z vrtenjem izbirnika naprej ali nazaj izberete pravilen odmerek.
SS: Steady State 
SS: stanje dinamičnega ravnovesja
Glucose Infusion Rate (mg/(kg*min)) 
Hitrost infuzije glukoze (mg/(kg*min))
It is therefore recommended that the patient always carries glucose-containing products. 
Zato je priporočljivo, da bolniki s sladkorno boleznijo vedno nosijo pri sebi živila, ki vsebujejo sladkor.
This medicinal product must not be used in insulin infusion pumps. 
Tega zdravila se ne sme uporabljati v infuzijskih črpalkah za insulin.
If you keep injecting in the same place, these reactions can become more severe and affect the amount of medicine your body gets. 
Če zdravilo nenehno injicirate na isto mesto, lahko te reakcije postanejo hujše in vplivajo na količino zdravila, ki jo telo dobi.
• Severe hypoglycaemic episodes, where the patient is not able to treat himself, can be treated with glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a trained person, or with glucose given intravenously by a healthcare professional. 
• Hude epizode hipoglikemije, kjer si bolnik sam ne more pomagati, je mogoče zdraviti z glukagonom (0,5 do 1 mg), ki ga intramuskularno ali subkutano aplicira ustrezno poučena oseba, ali z glukozo, ki jo intravensko aplicira zdravstveni delavec.
If you try to put it back on, you may accidentally stick yourself with the needle. 
Če ga poskušate znova namestiti na iglo, se lahko po nesreči zbodete.